Key Metrics
4.5
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
< 5
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
0.89
5-Year SI
5-year SI
- 0.88 2-year SI
- 0.89 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q3
Oncology
SJR
- Q3 Oncology
- Q3 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.19
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
4 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
31%
4 to 6 months
53%
7 to 9 months
13%
Above 9 months
3%
Did you find this useful?
Thank you for your feedback.
Indexed in the following public directories
-
Web of Science -
DOAJ -
SJR
Topics Covered
- Cancer
- Metabolism
- Overall survival
- Lung cancer
- Cancer genome
- Lymph node
- Biopsy
- Machine learning
- Radiation
- Progression-free survival
- Extracellular vesicles
- Immunotherapy
- Chemoradiotherapy
- Confidence interval
- Toxicity
- Breast cancer
- Hepatocellular carcinoma
- Lung
- Extracellular matrix
- Chemotherapy
Journal Specifications
| Overview | |
| Publisher | FRONTIERS MEDIA SA |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2950 |
| Publication Time | 14 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2011 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Waiver Policy | Visit website |
| Publication Time | 14 |
| Article Processing Charges | USD 2950 |
| Editorial Review Detail | |
| Editorial Team | Visit website |
| Review Process | Anonymous peer review |
| Review Url | Visit website |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
Planning to publish in Frontiers in Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
Prognostic value of disulfidptosis-associated genes in gastric cancer: a comprehensive analysis
- 4 Mar 25
- Frontiers in Oncology
-
Full paper
Corrigendum: A simplified frailty index and nomogram to predict the postoperative complications and survival in older patients with upper urinary tract urothelial carcinoma
- 4 Mar 25
- Frontiers in Oncology
-
Full paper
Retraction: Corrigendum: Upregulation of CCT-3 induces breast cancer cell proliferation through miR-223 competition and Wnt/b-catenin signaling pathway activation
- 4 Mar 25
- Frontiers in Oncology
-
Full paper
Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma
- 4 Mar 25
- Frontiers in Oncology
-
Full paper
A meta-analysis and systematic review of different cyclin-dependent kinase 4/6 inhibitors in breast cancer
- 4 Mar 25
- Frontiers in Oncology
-
Full paper
From tissue-specific to tissue-agnostic: HER2 overexpression and the rise of antibody-drug conjugates
- 3 Mar 25
- Frontiers in Oncology
Scite analysis
Powered by scite_
28.4k articles received 302.8k citations see all
- 9,617 Supporting
- 288,786 Mentioning
- 1,166 Contrasting
Editorial notices
- 137 Retractions
- 0 Withdrawals
- 348 Corrections
- 283 Errata
- 0 Expression of Concern
FAQs
How long has Frontiers in Oncology been actively publishing?
Frontiers in Oncology has been in operation since 2011 till date.
What is the publishing frequency of Frontiers in Oncology ?
Frontiers in Oncology published with a Continuous publication frequency.
How many articles did Frontiers in Oncology publish last years ?
In 2024, Frontiers in Oncology published 3774 articles.
What is the eISSN & pISSN for Frontiers in Oncology ?
For Frontiers in Oncology,eISSN is 2234-943X and pISSN is2234-943X.
What is Citescore for Frontiers in Oncology ?
Citescore for Frontiers in Oncology is 4.5.
What is SNIP score for Frontiers in Oncology ?
SNIP score for Frontiers in Oncology is 1.19.
What is the SJR for Frontiers in Oncology ?
SJR for Frontiers in Oncology is Q3.
Who is the publisher of Frontiers in Oncology ?
FRONTIERS MEDIA SA is the publisher of Frontiers in Oncology.